Serhii Arbuzov

Recent publications · Crossref

5 total works indexed

1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,873x

2. FCC-ee: The Lepton Collider

   · 2019 · cited 685x

3. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

   · 2021 · cited 585x

4. FCC-hh: The Hadron Collider

   · 2019 · cited 537x

5. FCC Physics Opportunities

   · 2019 · cited 525x

via Crossref · CC0

Wikidata facts

Image